Introduction
Cutibacterium acnes (C. acnes, formerly known as Propionibacterium acnes or P. acnes) has been implicated in chronic endophthalmitis following intraocular lens (IOL) surgery.1 Although typical postoperative endophthalmitis presents acutely with eye pain, conjunctival injection, and chemosis, chronic endophthalmitis may involve persistent low-grade inflammation, often with delayed onset and absence of these hallmark symptoms.1 This is attributed to the relatively low virulence of C. acnes, and sequestration within capsular remnants after IOL surgery.2 Without capsulectomy and IOL removal, C. acnes activity often recurs despite treatment of flares with intravitreal antibiotics and corticosteroids.1
Case Report
An 81-year-old woman with a history of bilateral cataract surgery and intraocular lens (IOL) placement (1996 in the left eye [OS], 2001 in the right eye [OD]), retinal detachment (RD) (OD, status post scleral buckle in 1985), and peripheral retinal tears (OS, status post laser retinopexy), presented in November 2016 with sudden onset of light perception vision in the left eye (Figure 1). At presentation, the left eye showed 3+ conjunctival injection, diffuse anterior chamber fibrin, and a layered hypopyon. No white plaque was observed on the IOL or lens capsule. Dilated fundus exam revealed an attached retina. She had no recent or intervening history of ocular trauma, intraocular surgery, or intravitreal injection. She received intravitreal vancomycin (1 mg/0.10 mL), ceftazidime (2.25 mg/0.10 mL), and topical corticosteroids. An aqueous humor sample showed 1+ leukocytes without bacterial growth. To assess possible endogenous endophthalmitis, a blood culture was obtained, which showed no growth.
One month later, the patient developed total RD in the left eye with tractional membranes. Examination showed improved anterior chamber inflammation, but significant vitreous debris remained. She underwent a diagnostic pars plana vitrectomy (PPV) prior to RD repair in order to determine the cause of endophthalmitis (December 2016). Vitreous biopsy from this PPV did not grow pathogens. The patient subsequently underwent RD repair (Figure 2). Multiple postoperative follow-up examinations revealed persistent mild inflammation with varying degrees fibrin or hypopyon.
Six weeks after RD repair and PPV, the patient presented again with acute vision loss in the left eye (counting fingers at 4 feet) with a 1-mm hypopyon. She received intravitreal vancomycin (1 mg/0.10 mL) and an aqueous tap grew C. acnes after 1 week (February 2017). Two months later, the patient underwent IOL removal and total capsulectomy. IOL/capsule culture grew only Staphylococcus epidermidis, a presumed contaminant. She was scheduled for earlier surgery but missed preoperative appointments due to hospitalization for community-acquired pneumonia. Following these interventions, her inflammatory symptoms resolved without recurrence.
Discussion
Although the literature often describes C. acnes as a common cause of chronic post-cataract endophthalmitis, cases are often indolent and marked by recurrent inflammatory episodes.1–3 The patient in this report had an interval of 252 months (21 years) without inflammation, reported trauma, or other known invasive intraocular procedure that could have introduced C. acnes into the eye between her cataract surgery and eventual presentation with endophthalmitis. This duration from surgery to symptom onset is substantially longer than that of previously documented cases of chronic post-IOL C. acnes endophthalmitis.1,2,4–6 Chien et al. reported one case with a 2-year delay between cataract surgery and onset of inflammatory symptoms.4 Aldave et al. reported 25 cases of C. acnes endophthalmitis, for which the average interval between cataract surgery and presentation for endophthalmitis was 4.5 months (range: 2 days to 16 months).1 Zambrano et al. reported nine cases with an interval of 4 months on average (range: 0.25 months to 12 months) between cataract surgery date and onset of endophthalmitis symptoms; the longest duration between surgery date and microbiologic confirmation was 38 months.6 The 36-patient cohort of post-IOL C. acnes endophthalmitis patients studied by Clark et al. had an average duration of 9 months between cataract surgery and first treatment; the longest such interval was 40 months.2
Given the atypical nature of a 21-year delay from surgery to presentation for a case of chronic post-IOL C. acnes endophthalmitis, other possible etiologies for this presentation are worth consideration. Although C. acnes could be a rare contaminant of microbiological sampling, it was felt that C. acnes was indeed the causative organism. The numerous C. acnes-negative cultures obtained throughout this patient's course may be due to the inherent difficulty in culturing this particular microorganism as a result of its relatively low virulence, slow growth rate, and sequestration within capsular remnants.7,8 Moreover, capsulectomy and lens removal, the typical definitive treatment for C. acnes chronic endophthalmitis, led to resolution of the patient's inflammation, further suggesting that C. acnes was indeed the most likely causative organism.1
Although the culture of the removed IOL and capsule remnants did grow Staphylococcus epidermidis, it is unlikely that this pathogen would explain the patients' episodes of inflammation over the months preceding definitive intervention or the initial presentation in the absence of recent intraocular surgical history and is most likely a contaminant in this case.
Clinicians should be aware that C. acnes may rarely cause a delayed acute and severe endophthalmitis. In our patient, C. acnes contributed to the development of a total RD in the setting of prior peripheral retinal tears. In this case, we demonstrate an atypical C. acnes endophthalmitis presentation; as such, clinicians should be vigilant in suspecting, diagnosing, and appropriately managing these cases.
References
- Aldave AJ, Stein JD, Deramo VA, Shah GK, Fischer DH, Maguire JI. Treatment strategies for postoperative Propionibacterium acnes endophthalmitis. Ophthalmology. 1999;106(12):2395–2401. doi:10.1016/S0161-6420(99)90546-8 [CrossRef] PMID:10599678
- Clark WL, Kaiser PK, Flynn HW Jr, Belfort A, Miller D, Meisler DM. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology. 1999;106(9):1665–1670. doi:10.1016/S0161-6420(99)90348-2 [CrossRef] PMID:10485532
- Deramo VA, Ting TD. Treatment of Propionibacterium acnes endophthalmitis. Curr Opin Ophthalmol. 2001;12(3):225–229. doi:10.1097/00055735-200106000-00015 [CrossRef] PMID:11389352
- Chien AM, Raber IM, Fischer DH, Eagle RC Jr, Naidoff MA. Propionibacterium acnes endophthalmitis after intracapsular cataract extraction. Ophthalmology. 1992;99(4):487–490. doi:10.1016/S0161-6420(92)31923-2 [CrossRef] PMID:1584564
- Meisler DM, Palestine AG, Vastine DW, et al. Chronic Propionibacterium endophthalmitis after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1986;102(6):733–739. doi:10.1016/0002-9394(86)90401-0 [CrossRef] PMID:3491543
- Zambrano W, Flynn HW Jr, Pflugfelder SC, et al. Management options for Propionibacterium acnes endophthalmitis. Ophthalmology. 1989;96(7):1100–1105. doi:10.1016/S0161-6420(89)32768-0 [CrossRef] PMID:2788852
- Hall GS, Pratt-Rippin K, Meisler DM, Washington JA, Roussel TJ, Miller D. Growth curve for Propionibacterium acnes. Curr Eye Res. 1994;13(6):465–466. doi:10.3109/02713689408999875 [CrossRef] PMID:7924410
- Piest KL, Kincaid MC, Tetz MR, Apple DJ, Roberts WA, Price FW Jr, . Localized endophthalmitis: a newly described cause of the so-called toxic lens syndrome. J Cataract Refract Surg. 1987;13(5):498–510. doi:10.1016/S0886-3350(87)80103-7 [CrossRef] PMID:3499503